Key takeaways
HCPCS code C1820 describes a Generator, neurostimulator (implantable), with rechargeable battery and charging system – a Level II HCPCS C-code maintained by CMS.
C1820 is valid only in hospital outpatient department (HOPD) and ambulatory surgical center (ASC) settings – never in physician offices or inpatient claims.
C1820 covers the device only. Surgical implantation services are billed separately using the appropriate CPT procedure codes.
Pabau’s claims management software helps outpatient billing teams track device code submissions, flag missing documentation before submission, and reduce claim denials.
HCPCS code C1820 describes a Generator, neurostimulator (implantable), with rechargeable battery and charging system. It is a Level II HCPCS C-code billed only in hospital outpatient department (HOPD) and ambulatory surgical center (ASC) settings.
In practice, most claim denials for this device code come from billing it in the wrong setting or confusing it with C1822, its high-frequency counterpart. So, this guide covers the fee schedule, setting rules, the C1820 vs C1822 distinction, modifiers, and the documentation requirements for a clean claim.
HCPCS code C1820: Definition and device descriptor
HCPCS code C1820 has a single official descriptor: Generator, neurostimulator (implantable), with rechargeable battery and charging system. Specifically, it is a Level II HCPCS C-code, a category of short-term codes assigned by the Centers for Medicare and Medicaid Services (CMS).
In other words, these short-term codes report specific devices used in hospital outpatient and ambulatory surgical center settings.
C-codes cover the device cost separately from the surgical procedure. So, C1820 reports only the implantable pulse generator (IPG) with its rechargeable battery and external charging system – nothing else.
C1820 code details at a glance
The table below sums up the key details of HCPCS code C1820. Before you bill, verify the current APC assignment and status indicator against the CMS OPPS Addendum B for the applicable fiscal year, since both are updated each year.
C1820 fee schedule and Medicare payment rates
Medicare pays for C1820 under the Outpatient Prospective Payment System (OPPS). So, payment is bundled into an Ambulatory Payment Classification (APC) group. As a result, the rate reflects the full cost of the device within the outpatient visit, not a standalone device fee.
Because OPPS payment rates are updated every fiscal year through CMS rulemaking, no third-party source should be treated as final.
Instead, for current rates, consult the CMS OPPS Addendum B annual file, which lists each C-code’s APC assignment, status indicator, and payment amount. Outpatient hospital coders can also use the fee schedule reference as a general billing framework guide.
Important: Pass-through device status for C-codes changes often, since CMS revises the OPPS final rule each year. So, always verify C1820’s current status indicator before submitting claims for a new fiscal year.
Where HCPCS code C1820 is used
C-codes, including HCPCS code C1820, are strictly outpatient codes. Indeed, they were created just for HOPD and ASC reporting and have no valid inpatient or physician-office use.
- Hospital Outpatient Department (HOPD): This is the primary setting for C1820. Here, the hospital bills the device code on a UB-04 claim form to report the implantable generator separately from the surgical procedure.
- Ambulatory Surgical Center (ASC): Similarly, ASCs report C1820 when the neurostimulator generator is implanted during an ASC visit. However, payment rates and status indicators may differ from HOPD rates.
- Not valid in physician offices: Physicians billing on a CMS-1500 form do not use C-codes. Instead, surgeon services are reported using the appropriate CPT procedure codes.
- Not valid for inpatient claims: By contrast, inpatient hospital stays use ICD-10-PCS procedure codes for device implantation, not HCPCS C-codes.
For billing teams managing outpatient neuromodulation cases. Pabau’s claims management software helps outpatient teams flag setting mismatches in real time.

C1820 vs C1822: Choosing the right code
Selecting the wrong generator code is one of the most common audit triggers in neuromodulation billing. Both C1820 and C1822 describe implantable neurostimulator generators with a rechargeable battery and charging system, according to the CMS HCPCS Level II descriptors. So, battery type does not separate the two codes.
Instead, the distinction is stimulation frequency: C1820 reports a non-high-frequency generator, and C1822 reports a high-frequency generator. Therefore, code selection must be driven by the stimulation therapy documented in the operative report, not by guesswork.
Key audit risk: Billing C1820 for a high-frequency stimulation system, or C1822 for a non-high-frequency system, is a coding error. As a result, it creates exposure in a Medicare audit.
Both codes describe rechargeable devices, so the mistake is a frequency mismatch, not a battery-type mismatch. Therefore, the operative report and device sticker or label must confirm the stimulation frequency that matches the billed code.
Clinical context: When is HCPCS code C1820 reported?
C1820 reports the implantable generator component in neuromodulation procedures. Notably, the same code applies across multiple clinical indications, as long as the device is a rechargeable implantable neurostimulator generator.
Common clinical scenarios that generate a C1820 claim include:
- Spinal cord stimulation (SCS): The most frequent use case. C1820 reports the rechargeable IPG implanted for chronic pain management, often alongside CPT 63685 (insertion of spinal neurostimulator pulse generator or receiver). Coders should pair the device claim with the correct diagnosis code, such as G59 for a documented neuropathic pain condition.
- Dorsal root ganglion (DRG) stimulation: DRG stimulators use the same generator category. Even so, code selection still depends on whether the implanted generator delivers high-frequency or non-high-frequency stimulation therapy.
- Deep brain stimulation (DBS): When a rechargeable IPG is implanted for movement disorders or other neurological indications in an outpatient or ASC setting.
- Other neuromodulation procedures: Any implantable neurostimulator generator with a rechargeable battery in an HOPD or ASC setting qualifies, regardless of the target anatomy.
C1820 covers the device only. In addition, the surgical CPT codes for lead placement and generator implantation are billed separately and are not bundled into the C-code.
Implantable-device billing isn’t unique to neuromodulation. Similar C-code documentation rules apply to plastic surgery practices tracking device serials and to regenerative medicine practices documenting implanted biologics in ASC settings.
Pro Tip
Review the device sticker or implant record immediately after surgery and before coding. Boston Scientific and Abbott both provide reimbursement guides that map model numbers to the correct HCPCS code – since C1820 and C1822 are both rechargeable, manufacturer documentation confirming the stimulation frequency is what actually reduces C1820 vs C1822 selection errors.
Applicable modifiers for C1820
HCPCS C-codes accept standard HOPD and ASC modifiers. The table below outlines modifiers commonly added to C1820. However, modifier use is subject to payer policy – so, always verify against current CMS HCPCS guidance before submission.
Modifiers should only be added when the clinical record and payer rules support them. Otherwise, adding modifiers without documented reason creates audit exposure rather than reducing it.
Billing instructions and common coding errors
A clean C1820 claim requires the right setting, the right device records, and the right code pairing. Below are the billing steps and the errors that derail them most often.
Step-by-step billing guidance
- Confirm the care setting is HOPD or ASC. C1820 is not valid on physician fee schedule claims.
- Retrieve the operative report and device implant label. Verify the generator is described as rechargeable with a charging system before selecting C1820 over C1822.
- Then, report C1820 on the UB-04 (HOPD) or the ASC claim form alongside the matching CPT surgical codes for the procedure.
- Next, apply modifiers only when payer policy and clinical documentation support them.
- Finally, attach supporting documentation: operative report, device sticker, and any prior authorization proof.
Most common coding errors
- Wrong setting: Submitting C1820 on a CMS-1500 physician claim. Remember, C-codes belong on facility claims only.
- C1820/C1822 mix-up: Billing C1820 for a high-frequency stimulation system, or C1822 for a non-high-frequency system. Both codes describe rechargeable generators – the operative report’s documented stimulation frequency must match the billed code.
- Bundling the surgical procedure: Reporting C1820 without the separate CPT codes for the surgical implantation – or assuming the CPT codes include the device. In fact, they do not.
- Missing device documentation: Submitting the claim without the implant sticker or device label attached to the record. More and more, payers require this for high-value device codes.
- Stale APC data: Using prior-year APC rates or pass-through status that CMS updated in the current OPPS final rule.
Billing teams that handle neurobehavioral screening procedure codes alongside neuromodulation device codes benefit from a structured workflow. That’s because separating device claim lines from procedure claim lines cuts down on cross-claim errors.
Likewise.

Documentation requirements for HCPCS code C1820
CMS audits for C1820 focus on one question: does the documentation trail connect the billed code to the device implanted in this patient? So, that trail must name the device, the patient, and the date of service.
The operative report must include:
- Clear description of the generator as having a rechargeable battery and charging system (not just “neurostimulator generator”)
- The device manufacturer name and model number
- The implant date and surgical approach
- The clinical indication for the neuromodulation therapy (mapped to the paired ICD-10 diagnosis code)
Supporting the operative report:
- Device implant label or sticker: Attach the product label from the device packaging to the patient record. This is the fastest way to settle an audit query about C1820 vs C1822 selection.
- Prior authorization proof: Many payers require pre-authorization for implantable neurostimulator generators. So, include the auth number on the claim and keep the authorization letter in the record.
- Trial stimulation documentation: For SCS, Medicare requires a successful trial stimulation period before permanent implant coverage is approved. So, documentation of the trial outcome belongs in the record.
Maintaining HIPAA-compliant clinical documentation matters most for high-value device codes like C1820. Audit scrutiny is higher here, so documentation gaps translate directly into recoupment risk.
Teams using Pabau can attach implant documentation directly to the patient record, keeping the complete audit trail in one place. Plus.
Related HCPCS and CPT codes
C1820 is never billed on its own. Instead, the complete neuromodulation claim includes CPT codes for the surgical procedure and may include extra HCPCS device codes for leads and other parts. So, use the AAPC HCPCS code reference to verify current descriptors for related C-codes.
Billing teams handling IVF CPT codes or coaching CPT codes alongside neuromodulation cases benefit from a single workflow. That way, one record can track device codes, surgical codes, and diagnosis codes together.
Pairing the device claim with the correct diagnosis code is a common step when preparing a neuromodulation claim.
Likewise, review coding conventions alongside ICD-11 8A00 to assign the diagnosis codes that support coverage for movement-disorder cases like DBS.
Related HCPCS codes
- HCPCS code C1762 — Connective Tissue, Human
- HCPCS code C1824 — Cardiac contractility modulation generator
- HCPCS Code C1826 — Implantable neurostimulator generator
- HCPCS code C1827 — Neurostimulator generator
How Pabau supports outpatient device code billing
Outpatient billing teams tracking C-codes like C1820 rely on spreadsheets or manual checklists to confirm setting, documentation, and modifier requirements before a claim goes out. However, that process breaks down as volume grows, or when staff turnover erases what the team knows about code-specific rules.
Practice management software like Pabau brings claims tracking into one place, so outpatient billing teams can flag missing device documentation before submission. It also helps confirm the right setting and check modifier use, catching incomplete records without a manual chart review.
As a result, teams see fewer denials tied to setting mismatches or missing implant documentation, and a faster path from surgery to a clean claim.
Manage device code submissions without the manual follow-up
Pabau’s claims management software helps outpatient billing teams track HCPCS device codes, flag documentation issues before submission, and reduce neuromodulation claim denials. See it in action.
Conclusion
Overall, claim denials for HCPCS code C1820 almost always come from avoidable mistakes: wrong setting, wrong code selection between C1820 and C1822, or missing device documentation.
In short, getting C1820 right means matching the code to the setting and the device to its documented stimulation frequency. So, keep the operative report and device sticker on file to support that match. Billing teams that build this check into their pre-submission workflow catch the setting and frequency errors that trigger most audits before a claim goes out.
Book a demo to see how Pabau keeps device documentation and claim tracking in one place for outpatient billing teams.
Continue your research
Need a structured approach to outpatient billing compliance? HIPAA compliance for medical offices covers the documentation and data security requirements that support clean claim submissions.
Want a reference on related HCPCS Level II coding context? CCSD and HCPCS codes overview shows how Level II device codes are structured across different healthcare billing systems.
Billing a pacemaker lead alongside a neurostimulator generator? C1779 covers the transvenous VDD single-pass pacemaker lead billed in the same device-code family.
Need a quick reference for neurological exam findings? Neuro exam cheat sheet gives clinicians a structured format for recording findings that support device-implant documentation.
Frequently asked questions
What does HCPCS code C1820 describe?
HCPCS code C1820 is a Generator, neurostimulator (implantable), with rechargeable battery and charging system. It is a Level II HCPCS C-code used by hospital outpatient departments and ambulatory surgical centers to report the implantable pulse generator device. That device code is reported separately from the surgical procedure used to implant it.
What is the difference between C1820 and C1822?
Both codes describe rechargeable generators, so battery type is not the distinction. C1820 applies to non-high-frequency stimulation therapy, and C1822 applies to high-frequency stimulation therapy. Code selection must be based on the stimulation frequency documented in the operative report – using the wrong code creates audit exposure. A non-rechargeable implantable neurostimulator generator is reported with HCPCS code C1767, not C1822.
Is C1820 used for spinal cord stimulators?
Yes. Spinal cord stimulation (SCS) is the most common clinical scenario for C1820. When a rechargeable implantable pulse generator is implanted in an HOPD or ASC setting for SCS, C1820 reports the device component. The surgical CPT codes for lead and generator implantation are billed separately.
Billing and audit FAQs
Where is HCPCS code C1820 used – inpatient or outpatient?
Outpatient only. HCPCS code C1820 is valid exclusively in hospital outpatient department (HOPD) and ambulatory surgical center (ASC) settings. It is not used on physician office claims (CMS-1500) or inpatient hospital claims, which use ICD-10-PCS codes for device implantation instead.
What modifiers apply to HCPCS code C1820?
Common modifiers appended to C1820 include -RT/-LT for laterality, -KX when coverage criteria have been met, and -GA when a signed ABN is on file. Modifier applicability depends on payer policy – verify against current CMS guidelines before appending modifiers to a claim.
Is C1820 a pass-through device code?
C-codes can carry transitional pass-through status under OPPS, but CMS periodically adds and removes codes from pass-through designation through the annual OPPS final rule. Verify C1820’s current pass-through status against the CMS OPPS Addendum B for the applicable fiscal year before submitting claims.